Business Medical Dialogues
    • facebook
    • twitter
    Sign in Signup
    • facebook
    • twitter
    Sign in Signup
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    Sign InRegister
    Business Medical Dialogues
    Sign inRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • drug patent

    Tag: drug patent

    You Searched For "drug patent"
    Stempeutics gets patent for stem cell drug Stempeucel from US Patent and Trademarks Office

    Stempeutics gets patent for stem cell drug Stempeucel from US Patent and Trademarks Office

    Medical Dialogues Bureau3 Nov 2019 4:25 AM GMT
    'The US patent is for the method of treating ischemia by administering pooled allogeneic mesenchymal stromal cells,' Stempeutics Research said in a sta...
    Merck loses bid to revive over Rs 18 crore patent verdict against Gilead

    Merck loses bid to revive over Rs 18 crore patent verdict against Gilead

    Farhat Nasim31 Oct 2019 9:57 AM GMT
    In 2016, a jury returned a verdict that Gilead Science's hepatitis C drugs Sovaldi and Harvoni infringed the patent, which Merck acquired when it bough...
    AstraZeneca sells European rights for schizophrenia drug Seroquel, Seroquel XR for USD 178 million

    AstraZeneca sells European rights for schizophrenia drug Seroquel, Seroquel XR for USD 178 million

    Farhat Nasim30 Oct 2019 11:55 AM GMT
    The treatment, Seroquel, and another version, Seroquel XR, have lost patent protection in Europe and Russia, AstraZeneca said. The drug variants are pr...
    Delhi HC given Green Signal to Natco Pharma for generic of Novartis cancer drug Ceritinib

    Delhi HC given Green Signal to Natco Pharma for generic of Novartis cancer drug Ceritinib

    Farhat Nasim1 Sep 2019 9:03 AM GMT
    New Delhi: In a major relief to Natco, the Delhi High Court has lifted a ban on Natco Pharma from manufacturing fresh stock of on-small cell lung...
    Pfizer, Mylan in talks to merge off-patent drugs business

    Pfizer, Mylan in talks to merge off-patent drugs business

    Medical Dialogues Bureau29 July 2019 4:00 AM GMT
    Mylan shareholders would receive a little more than 40 per cent of the newly formed entity, with Pfizer shareholders receiving the remainder, the perso...
    Price Ceiling, Compulsory licensing of patented medicines Necessary: Govt panel

    Price Ceiling, Compulsory licensing of patented medicines Necessary: Govt panel

    Medical Dialogues Bureau28 Jan 2019 7:20 AM GMT
    Worried about 'high prices' and 'unaffordability' of patented medicines in India, the Department of Pharmaceuticals (DOP) formed this inter-ministerial...

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 29 March 2022 11:15 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier

    This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
    verify here.

    Search only trustworthy HONcode health websites:

    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

    © 2020 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok
    X
    X